• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

荨麻疹和血管性水肿患者的生活质量:评估疾病负担

Quality of life in patients with urticaria and angioedema: assessing burden of disease.

作者信息

Weldon David

机构信息

Scott & White Clinic, College Station, Texas, USA.

出版信息

Allergy Asthma Proc. 2014 Jan-Feb;35(1):4-9. doi: 10.2500/aap.2014.35.3713.

DOI:10.2500/aap.2014.35.3713
PMID:24433591
Abstract

Patients with urticaria and/or angioedema have several reasons to have a poor quality of life (QoL). The intensity of pruritus and density of involvement compromise a patient's lifestyle as well as aggravate stressors that affect physical and psychiatric conditions. The burden of illness is significant in not only costs for emergent practitioner visits, but, often, unnecessary laboratory testing and medication expenses. Questionnaires that assess a patient's QoL serve to document benefit to therapies. Objectively documenting changes that are important to patients with urticaria and/or angioedema allows the patients and clinician to accurately assess effectiveness of therapies over long periods of time. Specific surveys that address urticaria (CU-Q2oL and UAS) and angioedema (AE-QoL questionnaire) allow simplified and sensitive assessments for patients with the corresponding condition. Common components of appropriate surveys assess not only intensity of pruritus and wheals but also impact on sleep, interpersonal relationships, and appearances. In considering the most important aspects of several surveys, an example of a survey is provided that focuses on the patient's perception of how their urticaria and/or angioedema impacts their QoL.

摘要

患有荨麻疹和/或血管性水肿的患者有多种导致生活质量低下的原因。瘙痒的强度和受累程度会影响患者的生活方式,并加剧那些影响身体和精神状况的应激源。疾病负担不仅体现在急诊就诊的费用上,还常常体现在不必要的实验室检查和药物费用上。评估患者生活质量的问卷有助于记录治疗效果。客观记录对荨麻疹和/或血管性水肿患者重要的变化,能使患者和临床医生长期准确评估治疗效果。针对荨麻疹(慢性荨麻疹生活质量问卷和荨麻疹活动度评分)和血管性水肿(血管性水肿生活质量问卷)的特定调查,能为相应病症的患者提供简化且敏感的评估。合适调查的共同组成部分不仅评估瘙痒和风团的强度,还评估对睡眠、人际关系和外貌的影响。在考虑多项调查的最重要方面时,给出了一个以患者对其荨麻疹和/或血管性水肿如何影响其生活质量的认知为重点的调查示例。

相似文献

1
Quality of life in patients with urticaria and angioedema: assessing burden of disease.荨麻疹和血管性水肿患者的生活质量:评估疾病负担
Allergy Asthma Proc. 2014 Jan-Feb;35(1):4-9. doi: 10.2500/aap.2014.35.3713.
2
How to Measure Disease Activity, Impact, and Control in Patients with Recurrent Wheals, Angioedema, or Both.如何衡量反复发作的风团、血管性水肿或两者兼具的患者的疾病活动度、影响和控制情况。
J Allergy Clin Immunol Pract. 2021 Jun;9(6):2151-2157. doi: 10.1016/j.jaip.2021.02.026.
3
How to assess disease activity in patients with chronic urticaria?如何评估慢性荨麻疹患者的疾病活动度?
Allergy. 2008 Jun;63(6):777-80. doi: 10.1111/j.1398-9995.2008.01726.x.
4
The Angioedema Quality of Life Questionnaire (AE-QoL) - assessment of sensitivity to change and minimal clinically important difference.血管性水肿生活质量问卷 (AE-QoL) - 评估变化的敏感性和最小临床重要差异。
Allergy. 2016 Aug;71(8):1203-9. doi: 10.1111/all.12900. Epub 2016 Jun 13.
5
Disease-specific impairment of the quality of life in adult patients with chronic spontaneous urticaria.慢性自发性荨麻疹成年患者特定疾病的生活质量损害
Korean J Intern Med. 2018 Jan;33(1):185-192. doi: 10.3904/kjim.2015.195. Epub 2016 Jun 1.
6
Urticaria: impact on quality of life and economic cost.荨麻疹:对生活质量和经济成本的影响。
Immunol Allergy Clin North Am. 2014 Feb;34(1):89-104. doi: 10.1016/j.iac.2013.09.011.
7
[Inducible urticaria and chronic spontaneous urticaria].[诱导性荨麻疹和慢性自发性荨麻疹]
Ann Dermatol Venereol. 2014 Nov;141 Suppl 3:S570-9. doi: 10.1016/S0151-9638(14)70160-7.
8
A Specialized Therapeutic Approach to Chronic Urticaria Refractory to H1-Antihistamines Improves Disease Burden: The Spanish AWARE Experience.一种针对对H1抗组胺药难治的慢性荨麻疹的专门治疗方法可减轻疾病负担:西班牙AWARE经验。
J Investig Allergol Clin Immunol. 2022 Jun 20;32(3):191-199. doi: 10.18176/jiaci.0661. Epub 2020 Dec 22.
9
Burden of Illness and Quality-of-Life Measures in Angioedema Conditions.血管性水肿疾病的疾病负担与生活质量衡量指标
Immunol Allergy Clin North Am. 2017 Aug;37(3):597-616. doi: 10.1016/j.iac.2017.04.005.
10
Quality of life in patients with urticaria.荨麻疹患者的生活质量
Allergy Asthma Proc. 2006 Mar-Apr;27(2):96-9.

引用本文的文献

1
From wheal to wellness: efficacy and safety of ligelizumab in chronic spontaneous urticaria: a systematic review and meta-analysis.从风团到健康:利吉珠单抗治疗慢性自发性荨麻疹的疗效与安全性:一项系统评价与荟萃分析
Arch Dermatol Res. 2025 Feb 27;317(1):503. doi: 10.1007/s00403-025-03966-w.
2
Risk calculator of the clinical response to antihistamines in chronic urticaria: Development and internal validation.慢性荨麻疹抗组胺治疗临床应答风险计算器的建立和内部验证。
PLoS One. 2024 Feb 23;19(2):e0295791. doi: 10.1371/journal.pone.0295791. eCollection 2024.
3
Burden of and Trends in Urticaria Globally, Regionally, and Nationally from 1990 to 2019: Systematic Analysis.
全球、地区和国家范围内的荨麻疹负担和趋势:系统分析。
JMIR Public Health Surveill. 2023 Oct 26;9:e50114. doi: 10.2196/50114.
4
Improving of psychological status and inflammatory biomarkers during omalizumab for chronic spontaneous urticaria.奥马珠单抗治疗慢性自发性荨麻疹期间心理状态及炎症生物标志物的改善
Future Sci OA. 2020 Aug 10;6(9):FSO618. doi: 10.2144/fsoa-2020-0087.
5
The usage, quality and relevance of information and communications technologies in patients with chronic urticaria: A UCARE study.慢性荨麻疹患者信息与通信技术的使用、质量及相关性:一项UCARE研究。
World Allergy Organ J. 2020 Oct 30;13(11):100475. doi: 10.1016/j.waojou.2020.100475. eCollection 2020 Nov.
6
A protocol for the development and internal validation of a model to predict clinical response to antihistamines in urticaria patients.用于开发和内部验证预测荨麻疹患者对抗组胺药物临床反应的模型的方案。
PLoS One. 2020 Oct 6;15(10):e0239962. doi: 10.1371/journal.pone.0239962. eCollection 2020.
7
Chronic Spontaneous Urticaria and Type 1 Diabetes Mellitus-Does Quality of Life Impairment Always Reflect Health Danger?慢性自发性荨麻疹与1型糖尿病——生活质量受损是否总是反映健康风险?
J Clin Med. 2020 Aug 4;9(8):2505. doi: 10.3390/jcm9082505.
8
Latin American chronic urticaria registry (CUR) contribution to the understanding and knowledge of the disease in the region.拉丁美洲慢性荨麻疹登记处(CUR)对该地区疾病的理解和认识所做的贡献。
World Allergy Organ J. 2019 Jun 13;12(6):100042. doi: 10.1016/j.waojou.2019.100042. eCollection 2019.
9
Efficacy and safety of Xiaofeng powder (xiao feng san) in treating urticaria: A protocol for a systematic review and meta-analysis of randomized controlled trials.消风散治疗荨麻疹的疗效与安全性:一项随机对照试验的系统评价与Meta分析方案
Medicine (Baltimore). 2018 Nov;97(45):e13039. doi: 10.1097/MD.0000000000013039.
10
Involvement of new oxidative stress markers in chronic spontaneous urticaria.新的氧化应激标志物与慢性自发性荨麻疹的关系。
Postepy Dermatol Alergol. 2017 Oct;34(5):448-452. doi: 10.5114/ada.2017.71110. Epub 2017 Oct 31.